P.A.W. CAPITAL CORP - GALMED PHARMACEUTICALS LTD ownership

GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 24 filers reported holding GALMED PHARMACEUTICALS LTD in Q1 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.

Quarter-by-quarter ownership
P.A.W. CAPITAL CORP ownership history of GALMED PHARMACEUTICALS LTD
ValueSharesWeighting
Q1 2022$318,000
-12.6%
200,0000.0%0.33%
-0.6%
Q4 2021$364,000
-34.8%
200,0000.0%0.33%
-32.7%
Q3 2021$558,000
-8.2%
200,0000.0%0.50%
-2.7%
Q2 2021$608,000
-11.4%
200,0000.0%0.51%
-15.6%
Q1 2021$686,000
+10.3%
200,0000.0%0.60%
+10.0%
Q4 2020$622,000
-11.9%
200,0000.0%0.55%
-28.5%
Q3 2020$706,000
+47.7%
200,000
+100.0%
0.77%
+42.0%
Q2 2020$478,000
+38.2%
100,0000.0%0.54%
+16.1%
Q1 2020$346,000
-40.1%
100,0000.0%0.47%
-24.4%
Q4 2019$578,000
+72.5%
100,000
+42.9%
0.62%
+47.4%
Q3 2019$335,000
-35.0%
70,0000.0%0.42%
-25.0%
Q2 2019$515,000
-29.9%
70,000
-22.2%
0.56%
-23.4%
Q1 2019$735,000
+19.5%
90,0000.0%0.73%
-5.7%
Q4 2018$615,000
-49.7%
90,0000.0%0.77%
-40.6%
Q3 2018$1,222,000
+8.0%
90,000
-5.3%
1.30%
+13.5%
Q2 2018$1,131,000
+103.1%
95,000
-5.0%
1.14%
+70.9%
Q1 2018$557,000
-42.0%
100,000
-4.8%
0.67%
-44.7%
Q4 2017$961,000
+0.1%
105,0000.0%1.21%
+20.1%
Q3 2017$960,000
+29.0%
105,000
-12.5%
1.01%
+35.0%
Q2 2017$744,000
+26.7%
120,0000.0%0.75%
+25.8%
Q1 2017$587,000
+39.4%
120,0000.0%0.59%
+24.6%
Q4 2016$421,000
+58.3%
120,000
+100.0%
0.48%
+66.4%
Q3 2016$266,00060,0000.29%
Other shareholders
GALMED PHARMACEUTICALS LTD shareholders Q1 2022
NameSharesValueWeighting ↓
BVF INC/IL 1,347,755$574,8180.02%
Virtu Financial LLC 31,633$130.00%
Western Wealth Management, LLC 29,537$12,5970.00%
Belpointe Asset Management LLC 14,050$5,9920.00%
TSFG, LLC 3,000$10.00%
ZRC WEALTH MANAGEMENT, LLC 100$430.00%
Allworth Financial LP 250$1070.00%
JANE STREET GROUP, LLC 13,189$5,6250.00%
RAYMOND JAMES & ASSOCIATES 138,040$58,8740.00%
BOURGEON CAPITAL MANAGEMENT LLC 500$2140.00%
View complete list of GALMED PHARMACEUTICALS LTD shareholders